Diabetes drug improves bone mass in mice with osteoporosis (AlphaGalileo, 24 March 2014)

24 Mar 2014


A study presented at the Society for Endocrinology BES conference investigates effects of GLP-1 agonists on bone mass and structure in a mouse model of osteoporosis.

Full article


Related Topics

Bone Adrenal Diabetes Metabolism Obesity Cardiovascular Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story